According to a filing, CHINARES PHARMA (03320) has announced the results of China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd. (000999) for the first nine months of 2026.

Total operating revenue came in at approximately RMB 21.41 billion, representing a year-on-year decline of 2.62%.

Net profit stood at approximately RMB 2.601 billion, down 10.28% compared with the same period a year earlier.